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Summary There is accumulating evidence of an increased risk of familial clustering of cancer in the first-degree relatives of lung cancer
probands. However, no explanation has been proposed for these epidemiological data. We reviewed 379 female non-small-cell lung cancer
(NSCLC) patients to obtain their family histories of malignancy. Among them, nine female NSCLC patients with three or more relatives
diagnosed with malignancy and 28 control patients without a family history of malignancy were selected to be analysed for instability at six
different microsatellite loci. We observed microsatellite instability (MSI) more frequently in the patients with three or more family histories of
malignancy (six out of nine, 67%) than the control patients (5 out of 28, 18%). The incidence of MSI in the former was significantly higher than
that in the control (P = 0.011: Fisher's exact test). We detected no significant difference in clinicopathological characteristics between the
cases with MSI and those without MSI, except for their family histories of cancer. Our results show that a significantly higher rate of MSI is
associated with familial clustering of malignancy. MSI could be one of the underlying mechanisms for familial clustering of malignancy in
female NSCLC patients.
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Although smoking is a well-accepted causal factor oflung cancer,
some investigators have raised the possibility that genetic factors
may play an important role in the aetiology oflung cancer. Several
reports showed that an increased familial risk for any cancer
including lung cancer was found among relatives of lung cancer
probands (Lynch et al, 1986; Ooi et al, 1986; Samet et al, 1986;
Gao et al, 1987; Sellers et al, 1987; Tsugane et al, 1987; Horwitz et
al, 1988; Wu et al, 1988; McDuffie et al, 1991; Osann, 1991; Shaw
et al, 1991; Goldgaretal, 1994). Furthermore, an increased risk for
cancerdevelopment was seen especially among relatives offemale
lung cancer probands and smoking acted synergistically with a
family history of malignancy for tumorigenesis of female lung
cancer (Osann, 1991). These authors suggested that a family
history oflung or any cancer could be considered as an additional
risk factorthat interacted with environmental factors. However, the
underlying genetic mechanisms in familial clustering of
malignancy have not been elucidated.
Microsatellite instability (MSI) has been described in various
cancer (Horii et al, 1994; Loeb, 1994; Wooster et al, 1994).
Patients with hereditary non-polyposis colorectal cancer (HNPCC)
were reported to have thehighestfrequency ofMSI, most ofwhom
had abnormal repair genes (Modrich, 1994). In contrast, there has
been little evidence in non-small-cell lung cancer (NSCLC) that
MSI is one of the definitive factors in tumorigenesis. Considering
the increased familial risk in NSCLC patients, these patients with a
family history of malignancy could be the subjects for a genetic
study. We have analysed the presence of MSI in female NSCLC
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patients with familial clustering of malignancy to determine its
relationship to the cancer clustering. To exclude the influence of
smoking as much as possible, we selected female patients whose
smoking habits were less than the average male in Japan
(Mitsudomi et al, 1989; Koo et al, 1990).
MATERIALS AND METHODS
Of the 1257 patients who had undergone resection of NSCLC at
our hospital between 1972 and 1995, 379 patients were female. A
family history was obtained from a self-administered question-
naire during the period 1972 to 1991, and from a medical record
interview form between 1992 and 1995. Patients were considered
to have a family history of malignancy if malignancy at any site
was noted in first-degree relatives (parents, siblings or children).
Histological typing of each case was determined according to the
World Health Organization classification (WHO, 1981) and the
stage ofdisease was based on the TNM classification ofthe Union
Intemationale Contre Cancer (Hermanek et al, 1992).
Nine out of ten patients with three or more relatives diagnosed
with malignancy, considered to have familial clustering of malig-
nancy, were selected to be analysed for the presence of MSI. One
patient was omitted from the study because a successful polymerase
chain reaction (PCR) amplification of the DNA was not obtained.
Twenty-eight patients without a family history of malignancy who
matched each ofthe selected patients in terms of age, sex, smoking
status and tumour extent were also selected as controls.
Paraffin-embedded tissues of lung carcinoma and dissected
mediastinal lymph nodes without metastasis were obtained from
the pathological files. Each block was sectioned into 10-,um slices;
one out of every three slices was stained with haematoxylin and
eosin to determine the areas to be selected. The circumscribed
tumour or lymph node tissue, about 100 mm2 in surface area, was
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scraped off the slide with a 18 G needle and placed into a 1.5-ml
microfuge tube. After deparaffinization with xylene, the tissues
were incubated for 12-24 h at 48°C in a digestion buffer
consisting of 10 mm Tris (pH 8.0), 100 mm sodium chloride,
25 mm EDTA, 0.5% sodium dodecyl sulphate (SDS), and
200 ,ug ml-' proteinase K. DNA was extracted with phenol/chloro-
form and precipitated with 80% ethanol (Shimizu et al, 1995).
Genetic alterations were examined at six microsatellite loci:
D2S123 (2p2l), D3S659 (3pl3), D3S966 (3p2l.3), D5S346
(5q21), WT1 (1lpl3), and TP53 (17pl3). All of these loci
contained dinucreotide (CA) repeats in it. The loci were selected
on the basis oftwo criteria: (a) a relatively high frequency ofMSI
has been reported in lung cancer specimens; and (b) instability of
these regions may be involved in the carcinogenesis oflung cancer
(Shridhar et al, 1994; Adachi et al, 1995; Ryberg et al, 1995). The
PCR primer sequences for these markers were obtained from the
Genome Data Base (NCBI, USA). PCR was performed in 20-,ul
volumes of a mixture containing 10 mM Tris (pH 8.3), 50 mM
potassium chloride, 1.5 mm magnesium chloride, 50 ,UM dNTP,
0.1 jM concentrations of each Cy 5-end-labelled primer
(Pharmacia Biotech, Uppsala, Sweden), 0.15 U ofTaq polymerase
(TaKaRa Biomedicals, Shiga, Japan), and 1 jl of DNA sample.
The reaction mixtures were heated to 95°C for 2 min and then
cycled 40-45 times in a DNA thermal cycler (Perkin Elmer,
California, USA) or GeneAmp PCR system 9600 (Perkin Elmer,
California, USA); each cycle consisted of30 s at 94°C for denatu-
ration, 1-2 min at 50-60'C for annealing, 1 min at72°C for strand
elongation, and 7 min at 72°C for final elongation. In cases using
45 cycles PCR, we performed PCR in two steps as follows: first,
half ofthe PCR mixture was used to amplify the target locus in 25
cycles, and then the other half of the mixture was added to the
Eppendorf tube to accomplish the remaining 20 PCR cycles,
resulting in 45 cycles in total. The PCRproducts were diluted with
a loading buffer consisting of 95% formamide, 20 mM EDTA
(pH 8.0) and Dextran blue, and denatured for 5 min at 98°C. The
solution was electrophoresed on 6% polyacrylamide gels
containing 8.3 M urea for 4 h at 34 W using an ALFred DNA
sequencer (Pharmacia Biotech, Uppsala, Sweden). The data were
processed by Fragment Manager (Pharmacia Biotech, Uppsala,
Sweden). To confirm the reproducibility ofthe experiment, all the
cases were examined at least twice by independently performed
PCRs and electrophoreses. MSI was defined as an additional two
or more bands in the tumour sample DNA when compared with
the normal tissue samples (Figure 1).
Correlation of MSI with various pathological factors including
histological type, pathological TNM grade of the primary lesion
and vascular invasion, as well as accompanying clinical features
was determined. Two-sided Fisher's exact test was used for
statistical analyses (Stat View 4.1J, Macintosh). A P-value of less
than 0.05 was taken to be significant.
RESULTS
Among 379 female lung cancer patients, 136 (35.9%) had a
family history of malignancy. The age of these 136 patients
ranged from 29 to 85 years old, with a median of 64 years. There
were no significant differences in clinicopathological features
between the cases with and without a family history of malig-
nancy (Table 1). Of these 136 patients, 102 had only one family
member with a history of malignancy, 24 had two, and ten had
three or more.
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Figure 1 Examples of microsatellite instability (MSI) and loss of
heterozygosity (LOH). MSI is shown at D5S346, D2S123, and TP53. LOH is
shown at D3S966. MSI was defined as an additional two or more bands in
the tumour sample when compared with the normal tissue samples.
N, normal tissue; T, tumour
The number of malignancies found in first-degree relatives of
these patients was as follows: 66 gastric cancers, 24 lung cancers,
21 colorectal cancers, 18 uterine cancers and 40 others with a
frequency ofeight or less (Table 2).
We analysed for the presence of MSI in nine of the female
patients with familial clustering of malignancy and 28 of those
without a family history of malignancy as a control group. MSI
was found in six (67%) outofninepatients with familialclustering
of malignancy and 5 (18%) out of 28 control patients. The
frequency ofMSI in the familial clustering group was significantly
higher than that in the control group (P = 0.011). MSI at two or
more loci was found in two (22%) out of the nine patients. The
frequency of MSI at two or more loci in the familial clustering
group was higher than that in the controls; however, it was not
statistically significant (P = 0.244). The characteristics of these
patients are shown in Table 3. The frequency ofMSI among all the
examined patients was 11% for D2S123, 5% forD3S659, 19% for
D3S966, 3% for D5S346, 5% for WT1, and 3% for TP53 respec-
tively. The number of informative cases at each locus was as
follows: 19 cases at D2S123, 26 cases at D3S659, 12 cases at
D3S966, 18 cases at D5S346, 21 cases at WTI, and 17 cases at
TP53. Loss of heterozygosity (LOH) was observed in 21% of all
the patients at D2S123, 19% at D3S659, 33% at D3S966, 17% at
D5S346, 19% at WT1 and 24% at TP53.
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Table 1 Profiles of female patients with and without a family history of malignancy
Total With FHa Without FHa
(n = 379) (n = 136) (n = 243)
Age (years)
Range 25-85 29-85 25-83
Median 62 64 61
Pack-years smoked
0 263 91 172
1-29 70 30 40
30 46 15 31
Histology
Adenocarcinoma 315 108 207
Squamous cell carcinoma 49 21 28
Large-cell carcinoma 4 3 1
Adenosquamous carcinoma 10 4 6
Stage
1 191 71 120
11 27 7 20
IIIA 96 37 59
IIIB 17 2 15
IV 48 19 29
The number of malignancies in first-degree relatives
1 102 102 0
2 24 24 0
3 or more 10 10 0
a FH, family history of malignancy.
Table 2 Malignancies found in first-degree relatives of female lung cancer
patients with a family history of malignancy
Total Three or more FHs'
Stomach 66b 14
Lung 24 6
Colon and rectum 21 1
Uterus 18 2
Breast 7 1
Oesophagus 7 0
Head and neck 8 2
Liver 5 1
Bladder 4 1
Ovary 4 0
Pancreas 3 0
Prostate 2 1
a FH, Family history of malignancy, b number of first-degree relatives affected
with any malignancy.
Clinicopathological differences between the patients with
familial clustering of malignancy and the control patients was not
significant. Clinicopathological features in these 37 female
patients were compared with the patients with MSI and those
without MSI (Table 4). There were no significant differences
between these two groups except for the presence offamily history
of malignancy. Gastric cancer was the most frequent malignancy
in the relatives of the patients with MSI followed by lung cancer.
In the relatives ofthe patients without MSI, no malignancies other
than gastric, lung or colorectal cancer were found.
DISCUSSION
We examined the presence of MSI in female lung cancer
patients with a familial clustering of malignancy and found that a
significantly higher rate of MSI was associated with familial clus-
tering of malignancy. We selected female patients for this study
based on these criteria: (a) we attempted to exclude the influence
ofsmoking as much as possible as Japanese women were reported
to smoke less than males (Mitsudomi et al, 1989; Koo et al, 1990);
and (b) an increased familial risk for any cancer was shown espe-
cially in female lung cancer patients (Osann, 1991). Moreover, we
narrowed down thepatients to those with three ormore first-degree
relatives with malignancy for the investigation ofMSI because we
considered that such patients might have a strong genetic back-
ground.
Several reports have described an aggregation of lung cancer
and other malignancies in isolated families (Brisman et al, 1967;
Joishy et al, 1977; Goffman et al, 1982). Tokuhata et al reported
the first epidemiological evidence of a possible role of genetic
factors in lung cancer development (Tokuhata et al, 1963). Other
epidemiological studies showed that a risk for lung, or any cancer,
is increased up to about five times in the relatives of lung cancer
patients (Lynch et al, 1986; Ooi et al, 1986; Samet et al, 1986; Gao
et al, 1987; Sellers et al, 1987; Tsugane et al, 1987; Horwitz et al,
1988; Wu et al, 1988; McDuffie et al, 1991; Osann, 1991; Shaw et
al, 1991; Goldgar et al, 1994). Despite these studies, the under-
lying genetic mechanisms in familial clustering of malignancy
remain to be disclosed.
In this study, we found a family history of malignancy in 136
(35.9%) of female lung patients and this frequency was slightly
lower than that in a previous report (Osann, 1991). Three or more
family members diagnosed with malignancy were found in 10
(7.3%) out of the 136 patients. We found MSI in 67% of these
patients. This frequency is higher than that in previous reports in
which an affected single microsatellite locus was observed in
6-34% of NSCLC patients (Shridhar et al, 1994; Adachi et al,
1995; Fong et al, 1995; Ryberg et al, 1995). It is difficult to
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Table 3 Clinicopathological features and the presence of MSI and LOH in 24 female lung cancer patients
Age PY" Stage Histologyb Family historyc
Case 1
Case 2
Case 3
Case 4
Case 5'
Case 6
Case 7
Case 8
Case 9
Case 10
Case 11
Case 12
Case 13
Case 149
Case 15
Case 16
Case 17
Case 18
Case 19
Case 20
Case 21
Case 22
Case 23
Case 24
Case 25
Case 26
Case 27
Case 28
Case 29
Case 30
Case 31
Case 32
Case 33
Case 34
Case 35
Case 36
Case 37
78
72
64
71
73
47
74
85
69
74
72
70
73
70
57
72
80
64
70
51
56
58
60
75
73
67
62
67
65
72
72
46
78
41
63
59
34
0
36
18
0
5
1
0
0
0
0
0
0
0
8
15
0
23
5
7
0
0
0
0
0
0
0
0
0
0
0
0
58
0
0
0
0
Illa
IV
lla
IV
lila
lila
lila
Illa
Illa
IV
IV
IV
lla
lila
Ad
SqCC
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
SqCC
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
5
4
3
3
3
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
MSid
1 4
2
0
0
1
0
0
0
1
2
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
LOHO
0/3
0/2
1/3
0/3
0/1
0/3
1/4
1/1
0/4
1/3
0/3
0/4
0/1
1/2
1/2
0/4
2/6
0/4
0/4
0/2
1/3
0/4
0/1
0/2
0/2
1/2
0/4
0/3
0/2
2/3
1/3
1/5
4/6
2/3
1/4
1/5
3/3
a PY, pack-years smoked. bAd, adenocarcinoma; SqCC, squamous cell carcinoma. c Family history of malignancy. The number
of malignancies found in first-degree relatives. d MSI, Microsatellite instability; the number of the loci in which replication errors
were detected. e LOH, Loss of heterozygosity; the number of LOH/the number of informative loci. ITwo loci (D2S123, WT1)
were not evaluable because of a failure in amplification by PCR. g One locus (D2S123) was not evaluable because of a failure in
amplification by PCR.
compare these results because the number of loci examined and
their locations differ from those in our study. We selected, there-
fore, an additional 28 patients without a family history of malig-
nancy as a matched control and found MSI in 20% of these
patients. The difference in the frequency of MSI between the
cancer probands and the controls was statistically significant.
Although MSI has been reported to be a causal genetic abnor-
mality for HNPCC, this finding suggests that MSI could also play
an important role in familial clustering of malignancy in female
NSCLC patients. MSI might be associated with hereditary lung
cancerpredisposition because MSI could be a secondary event due
to the defect of MLH1 mismatch repair gene on chromosome 3p,
which is reported to be unstable chromosome in lung cancer. Had
we been able to obtain malignant tissues from the relatives and
examined those samples, the results would have been more conclu-
sive. Unfortunately, these samples were not available, so further
prospective study is needed to confirm a role of the instability in
these relatives. We also found that the frequency of MSI at two or
more loci in the patients with familial clustering of malignancy
was higher than that in the control patients, although this differ-
ence was not statistically significant. The reason why the differ-
ence was not significant is probably attributed to the small number
ofthe examined patients or loci.
MSI at D2S123 and at D3S966 were frequently found but the
other loci were not. MSI was found in 11% of all the patients at
D2S123 and the frequency was higher than that of the previous
study (Fong et al, 1995). In NSCLC, the highest frequency ofMSI
was reported to be seen at loci on chromosome 3p (20-30%)
(Shridhar et al, 1994; Ryberg et al, 1995). In this study, MSI at
D3S966 was detected in 19% ofall the patients, which was consis-
tent with the previous reports. The locus specificity in MSI has
been suggested and the affected loci might be different in every
malignancy (Wooster et al, 1994). There may be some relation
between the familial clustering of malignancy and the high rate of
MSI at D2S123 and D3S966.
The frequency of LOH found in this study was generally lower
than that in previous reports (Tsuchiya et al, 1992; Hung et al,
1995). This may be due to underestimation of LOH because of the
lack ofvery precise microdissection. The admixture ofstromal cells
in NSCLC even in microdissection led to such underestimation of
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Table 4 Clinicopathological characteristics of 37 female lung cancer patients with or without microsatellite
instability
MSI positive MSI negative
(n=11) (n=26)
Age Median (range) 71 (64-85) 64 (34-80)
Family historya Yes/no 6/5 3/23
Smoking history Yes/no 3/8 8/18
Pack-years smoked Median (range) 0 (0-36) 0 (0-58)
Pathological stage l/II/III/IV 5/0/3/3 17/1/6/2
Histology Ad/SqCCb 10/1 26/1
Vascular invasion Yes/no 8/3 12/14
Malignancy found in first-degree relatives
Total 21 8
Stomach 10 4
Lung 3 3
Colorectum 0 1
Uterus 2 0
Breast 1 0
Head and neck 2 0
Liver 1 0
Bladder 1 0
Prostate 1 0
a Family history of malignancy. b Ad/SqCC, adenocarcinoma/squamous cell carcinoma.
GA 40 GA 62
Figure 2 The family tree of case 2 indicating relatives diagnosed with
malignancy. GA, gastric cancer; UT, uterine cancer; LC, lung cancer. The
number shows age of the relatives
LOH. Otherwise, the difference of used primers from previous
reports led to the difference ofthe frequency ofLOH. To know the
exact frequency ofLOH, a very precise microdissection would be
needed. No significant relationship between MSI phenotype and
LOH was found in this study.
One patient with familial clustering of malignancy (case 2)
showed high frequency of MSI (four out of six loci). The pedigree
of the patient is shown in Figure 2. We noted that these cancers in
relatives developed at arelatively young age and that the sites ofthe
cancers were those that were sometimes seen in HNPCC. Although
we could notfind colon cancer in the family and could not diagnose
the patient as HNPCC, the patient might have a defect in the repair
genes causing the similar spectrum ofcarcinogenesis.
Although Adachi et al (1995) reported that MSIs were detected
more frequently in advanced lung caincers and concluded that
MSIs appeared to be a late event in tumourprogression, there were
no significant differences in clinicopathological characteristics
between the groups with or without MSI in the study.
Adenocarcinoma is the most frequent subtype seen in women
(Colby et al, 1995). This tendency was also found in this study. As
almost all the examined cases were adenocarcinoma, and only a
small number ofsquamous cell carcinomas (SqCC) were included,
our results might not be applicable to female SqCC, which has
been reported to be most frequently associated with a family
history ofcancer (Ambroxone et al, 1993).
Types of malignancy found in the relatives of MSI positive and
negative cases did not differ significantly. The most frequent site
was stomach followed by lung. The same distribution of malig-
nancy site was found in the family with clustering of malignancy
as in cancer patients in Japan (Hanai, 1994). Thus, there seems to
be little relationship between the presence of MSI and the site of
malignancy found in the relatives of a cancser proband. These find-
ings suggest that the putative defects in the fa'milies with clustering
of malignancy might make them more sensitive to a wide variety
of environmental carcinogens. Further molecular studies focused
on individual family member as well as a cancer proband are
necessary to draw a definite conclusion.
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